| Literature DB >> 32317787 |
Christian P Schaaf1,2,3, Catalina Betancur4, Ryan K C Yuen5,6, Jeremy R Parr7, David H Skuse8, Louise Gallagher9, Raphael A Bernier10,11, Janet A Buchanan5, Joseph D Buxbaum12,13, Chun-An Chen2, Kira A Dies14, Mayada Elsabbagh15, Helen V Firth16, Thomas Frazier17, Ny Hoang5, Jennifer Howe5, Christian R Marshall5, Jacques L Michaud18, Olivia Rennie5, Peter Szatmari19,20, Wendy K Chung21, Patrick F Bolton22, Edwin H Cook23, Stephen W Scherer24,25,26, Jacob A S Vorstman27,28,29.
Abstract
Autism spectrum disorder (ASD) is often grouped with other brain-related phenotypes into a broader category of neurodevelopmental disorders (NDDs). In clinical practice, providers need to decide which genes to test in individuals with ASD phenotypes, which requires an understanding of the level of evidence for individual NDD genes that supports an association with ASD. Consensus is currently lacking about which NDD genes have sufficient evidence to support a relationship to ASD. Estimates of the number of genes relevant to ASD differ greatly among research groups and clinical sequencing panels, varying from a few to several hundred. This Roadmap discusses important considerations necessary to provide an evidence-based framework for the curation of NDD genes based on the level of information supporting a clinically relevant relationship between a given gene and ASD.Entities:
Mesh：
Year: 2020 PMID： 32317787 DOI： 10.1038/s41576-020-0231-2
Source DB: PubMed Journal: Nat Rev Genet ISSN： 1471-0056 Impact factor: 53.242